<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-TTXG4N64" height="0" width="0" style="display:none;visibility:hidden" aria-hidden="true"></iframe>

PATENTS, GRANTS & AWARDS

US Patents

Cytopeutics is a Malaysian stem cell company granted with several USA Patents for acute stroke, diabetes and macular oedema treatment with cell-based composition, as well as local patents for treatment involving heart, stroke, diabetes, autoimmune disease, critical limb ischemia and eye disease.

US Patent

US Patent for Acute Stroke

[No. 10,278,993]

US Patent for Diabetes

[No.11,052,119]

US Patent for Vernal Keratoconjunctivitis

[No. 10,828,332]

Malaysia Patents

Malaysia Patent for Heart

Malaysia Patent for Heart

No. MY- 171690-A

Malaysia Patent for Stroke

Malaysia Patent for Stroke

No. MY-173966-A

Malaysia Patent for Diabetes

Malaysia Patent for Diabetes

No. MY-171193-A

Malaysia Patent for Macular Oedema

Malaysia Patent for Macular Oedema

No. MY-171311-A

Malaysia Patent for Vernal Keratoconjunctivitis

Malaysia Patent for Vernal Keratoconjunctivitis

No. MY- 173386-A

Awards

Malaysia Health and Wellness Brand Awards
2017 – 2019

Endorsed by Ministry of Health, Malaysia

Brand Laureate Awards

2023 Brand ICON Leadership Award (Dr Chin SP)
2015-2016 SMEs Best Brands in Biotechnology Cell-Based Research & Treatment

Medical Technology – Health & Beauty Awards
2015-2016

by Long Life Magazine

SME 100 Awards 2015 Fast Moving Companies

by SME & Entrepreneurship Magazine

Grants

Ministry of Higher Education

FRGS 2010 – Kidney Research
ERGS 2012 – Cardiomyopathy Treatment

SMARTFUND for Pioneering GVHD Treatment

Awarded by Ministry of Science Technology, and Innovation (MOSTI)

Send Us a Message

Sitemap

About Us

Get In Touch

Phone
Mail
ENG / CN
ENG / BM

× Subject MessageSend

Copyright © Cytopeutics Sdn. Bhd. (Company No:200701018117 (776128-H)). Website managed by Exabytes. All rights reserved.